The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor.
about
ADAM-10 protein is present in human articular cartilage primarily in the membrane-bound form and is upregulated in osteoarthritis and in response to IL-1alpha in bovine nasal cartilageEsculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin MCyclic tensile strain suppresses catabolic effects of interleukin-1beta in fibrochondrocytes from the temporomandibular jointIn vivo model of cartilage degradation--effects of a matrix metalloproteinase inhibitor.IL-1 has no direct role in the IGF-1 non-responsive state during experimentally induced arthritis in mouse knee joints.Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosisMetalloproteinases: their role in arthritis and potential as therapeutic targets.Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro.A mouse model of ethanol dependent pancreatic fibrosisBiomimetic molecules lower catabolic expression and prevent chondroitin sulfate degradation in an osteoarthritic ex vivo modelTumor necrosis factor alpha-dependent proinflammatory gene induction is inhibited by cyclic tensile strain in articular chondrocytes in vitroCyclic tensile strain acts as an antagonist of IL-1 beta actions in chondrocytesStromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.Differential detection of type II collagen N-terminal and C-terminal denaturation epitopes in degrading cartilage.The metabolic dynamics of cartilage explants over a long-term culture period.Type II and VI collagen in nasal and articular cartilage and the effect of IL-1alpha on the distribution of these collagens.Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.Attenuation of N-nitrosodiethylamine-induced liver fibrosis by high-molecular-weight fucoidan derived from Cladosiphon okamuranus.Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor.Host metalloproteinases in Lyme arthritis.Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.Aggrecan protects cartilage collagen from proteolytic cleavage.Autologous solution protects bovine cartilage explants from IL-1α- and TNFα-induced cartilage degradation.Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation.
P2860
Q28213603-14B55BF7-B4A6-404E-91DF-0C7FF597DC69Q28345787-4E7F885B-26B0-4D6A-8ED6-97FF614925CCQ28361075-347288FF-910B-49D2-A453-9C559DE7B679Q33578246-B3163C8C-2D98-493B-8657-AE2CFA71B31BQ33578584-FF92D30E-4E0F-44B5-9A57-D7BCA57F3AC9Q33760250-005CA084-0413-4D42-BA42-544E155C42A8Q34984527-B7E167AB-9722-4B9F-8BE1-FAC9C9647830Q35056019-E5635715-0263-41B5-A4EA-7B1DCB4272EAQ35551055-C8440C73-06C3-4EBB-8780-0E772CDD4426Q35597813-7078754E-B116-4DD3-B5C1-B3ACAFF3A44EQ36567581-238B283B-9C07-478B-8CEE-028B7127DBA9Q37104087-CC02E4C4-4095-4830-BE1D-A6BAB54905BBQ37140082-ACC8651D-922C-44AB-985B-794BA79F2B06Q37641516-830AE9DF-A298-44CB-8476-907A2B8D3951Q37642523-E91491AF-7071-4532-A66A-87279561DA08Q38258884-39D4FE92-6676-4E45-B664-F8666151546EQ39975284-E681408A-C168-48EC-9B44-0FE93BD96043Q40790873-17E1D0FD-5D78-478F-88D3-1837A2EC9234Q40848847-32B816B6-517C-4ED1-8BBA-83518F4477B0Q42099549-C7976BE1-C12F-46A3-91D6-06B2D60DF19BQ42136540-AF693095-430D-4A18-B7A0-DE1D9E7F1F79Q42873630-70BE86F2-C9BA-40AC-96EF-DE616F43F7A3Q43264390-6DCDB83E-78DF-4BEC-87E2-9FB0931D4E63Q43641032-FA435C79-9096-4957-8A10-80105D4171E8Q43760463-D9674626-C0BC-4818-8E93-D3CC99BA57F5Q47724408-C760A51C-BD68-4F2C-A7C6-206363900387Q47728669-71ECB9BA-1132-4722-9959-EBEB89C5961EQ49106201-F1011FE6-2313-4D8C-9DEF-EE01E180C265Q53622506-CC8CE75D-ED21-4B5B-9458-B4A3C4960CBC
P2860
The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
The prevention of collagen bre ...... ar weight synthetic inhibitor.
@en
The prevention of collagen bre ...... ar weight synthetic inhibitor.
@nl
type
label
The prevention of collagen bre ...... ar weight synthetic inhibitor.
@en
The prevention of collagen bre ...... ar weight synthetic inhibitor.
@nl
prefLabel
The prevention of collagen bre ...... ar weight synthetic inhibitor.
@en
The prevention of collagen bre ...... ar weight synthetic inhibitor.
@nl
P2093
P356
P1476
The prevention of collagen bre ...... ar weight synthetic inhibitor.
@en
P2093
P304
P356
10.1006/BBRC.1994.1673
P407
P577
1994-05-01T00:00:00Z